Research
To provide the best treatments and care to patients with scleroderma, we need to perform research. To perform research, we need patients.
Because scleroderma is rare, performing clinical research in these diseases can be challenging. As a leader in scleroderma, we partner with patients and other scientists to move the field forward. The Penn Scleroderma Center is at the forefront of cutting-edge clinical and translational research. Penn has led on many research projects in scleroderma and has participated in numerous major clinical trials in scleroderma. We continue to direct innovative studies to advance our knowledge of scleroderma, including through clinical trials, genetic studies, and laboratory-based research.
|
|
|
|
|
